Published in 2016, the study showed that liraglutide reduced the risk of cardiovascular disease which is one of the most common causes of death in patients with type 2 diabetes
VP13 Estimating Meaningful Score Differences and Meaningful Score Regions for the PROMIS Pediatric Asthma Impact Scale Jing Yuan 1 , Li Lin 2 , Kevin Weinfurt 2 , Nicole Lucas 2 , Allison Burbank 3 , Michelle Hernandez 3 , I-Chan Huang 4 , Bryce Reeve 1 1 Duke University, Durham, North Carolina, USA, 2 Duke University School of Medicine, Durham, North Carolina, USA, 3 University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA
GLP-1 receptor agonists are licensed for type 2 diabetes and weight management, not specifically for cholesterol reduction
Semaglutide GLP-1 is a GLP-1 agonist, known as a Glucagon-Like Peptide-1, which works on receptors in the brain as well as the pancreas to cause a decrease in appetite along with slowing of the digestion process which leads to feeling full longer
[Crossref] Nakanishi H, Kurosaki M, Tamaki N (2015) L-carnitine Reduces Muscle Cramps in Patients with Cirrhosis